TR199802137T2 - Use of phosphonic acid esters in relation to functional dysregulations of the brain and depression. - Google Patents

Use of phosphonic acid esters in relation to functional dysregulations of the brain and depression.

Info

Publication number
TR199802137T2
TR199802137T2 TR1998/02137T TR9802137T TR199802137T2 TR 199802137 T2 TR199802137 T2 TR 199802137T2 TR 1998/02137 T TR1998/02137 T TR 1998/02137T TR 9802137 T TR9802137 T TR 9802137T TR 199802137 T2 TR199802137 T2 TR 199802137T2
Authority
TR
Turkey
Prior art keywords
brain
depression
acid esters
phosphonic acid
functional
Prior art date
Application number
TR1998/02137T
Other languages
Turkish (tr)
Inventor
Maurer Fritz
Schmidt Bernard
Lensky Stephan
Van Der Staay Franz-Josef
Joseph Fanelli Richard
Ross Britelli David
Original Assignee
Troponwerke Gmbh & Co. Kg
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke Gmbh & Co. Kg, Bayer Aktiengesellschaft filed Critical Troponwerke Gmbh & Co. Kg
Publication of TR199802137T2 publication Critical patent/TR199802137T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu bulus, beyin ve depresyonun islevsel düzensizliklerinin engellenmesi ve iyilestirilmesi için fosfonik asit esterlerinin kullanimina iliskindir.This invention relates to the use of phosphonic acid esters for the prevention and healing of functional disorders of the brain and depression.

TR1998/02137T 1996-04-25 1997-04-17 Use of phosphonic acid esters in relation to functional dysregulations of the brain and depression. TR199802137T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19616471A DE19616471A1 (en) 1996-04-25 1996-04-25 Phosphonic acid ester for the treatment of brain disorders and depression

Publications (1)

Publication Number Publication Date
TR199802137T2 true TR199802137T2 (en) 1999-02-22

Family

ID=7792381

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/02137T TR199802137T2 (en) 1996-04-25 1997-04-17 Use of phosphonic acid esters in relation to functional dysregulations of the brain and depression.

Country Status (19)

Country Link
EP (1) EP0896540A1 (en)
JP (1) JP2000510455A (en)
KR (1) KR20000010611A (en)
AR (1) AR006870A1 (en)
AU (1) AU2462397A (en)
BG (1) BG102864A (en)
BR (1) BR9709300A (en)
CA (1) CA2252567A1 (en)
CZ (1) CZ343498A3 (en)
DE (1) DE19616471A1 (en)
HU (1) HUP9903366A3 (en)
ID (1) ID16678A (en)
IL (1) IL126698A0 (en)
NO (1) NO984964L (en)
PL (1) PL333464A1 (en)
SK (1) SK146398A3 (en)
TR (1) TR199802137T2 (en)
WO (1) WO1997039756A1 (en)
ZA (1) ZA973538B (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1078370B (en) * 1958-09-16 1960-03-24 Norddeutsche Affinerie Pest repellants
US3069312A (en) * 1960-09-28 1962-12-18 California Research Corp N-substituted dimethyl 1-carbamoyloxy-2, 2, 2-trichloroethyl phosphonates as insecticidal compositions
NL292791A (en) * 1962-05-16 1900-01-01
DE1193044B (en) * 1963-08-05 1965-05-20 Bayer Ag Process for making phosphorylated urethanes
DE2512375A1 (en) * 1975-03-21 1976-09-30 Bayer Ag 1-HYDROXY-2,2,2-TRICHLORAETHANE THIONOPHOSPHONIC ACID DIAL KYLESTER, METHOD FOR THEIR PRODUCTION AND THEIR USE AS INSECTICIDES
US4950658A (en) * 1988-12-06 1990-08-21 Board Of Trustees Of Southern Illinois Univ. Method of medical treatment of Alzheimer's disease

Also Published As

Publication number Publication date
ID16678A (en) 1997-10-30
SK146398A3 (en) 1999-06-11
CZ343498A3 (en) 1999-02-17
PL333464A1 (en) 1999-12-20
AR006870A1 (en) 1999-09-29
BG102864A (en) 1999-09-30
HUP9903366A3 (en) 2000-08-28
WO1997039756A1 (en) 1997-10-30
HUP9903366A2 (en) 2000-07-28
DE19616471A1 (en) 1997-10-30
NO984964D0 (en) 1998-10-23
BR9709300A (en) 1999-08-10
EP0896540A1 (en) 1999-02-17
AU2462397A (en) 1997-11-12
ZA973538B (en) 1997-11-18
CA2252567A1 (en) 1997-10-30
IL126698A0 (en) 1999-08-17
NO984964L (en) 1998-12-22
JP2000510455A (en) 2000-08-15
KR20000010611A (en) 2000-02-25

Similar Documents

Publication Publication Date Title
HK1026144A1 (en) Aryl ureas for the treatment of inflammatory or immunomodulatory diseases.
ATE259215T1 (en) COMPOSITION FOR REGULATING SKIN APPEARANCE
ES2154252T1 (en) INHIBITION OF QUINASA P38 USING DIFENYL-SIMETRIC AND ASYMETRIC UREAS.
TR200002773T2 (en) Smilagen and anzurogenin-D and their use for the treatment of Alzheimer's.
ES2154253T1 (en) INHIBITION OF THE ACTIVITY OF QUINASA P38 USING REPLACED HETEROCICLICAL UREAS.
ES2155817T1 (en) INHIBITION OF THE ACTIVITY OF QUINASA P38 USING HETEROCICLIC UREAS REPLACED WITH ARILO AND HETEROARILO.
MY125142A (en) Arylsulphonamides and analogues
DE69634951D1 (en) TOPICAL USE OF BETULINIC ACID FOR THE TREATMENT OF POOR MELANOMA
TR199901949T2 (en) From lymphosis to t�m�rler i�in �areler.
ATE271865T1 (en) USE OF CHOLINESTERASE INHIBITORS TO TREAT ATTENTION DEFICIENCY DISORDER
BR9813778A (en) Use of at least one fucan.
DE69934096D1 (en) COMPOSITIONS AND METHODS OF WOUND HEALING
ATE235245T1 (en) PHARMACEUTICAL COMPOSITION
DE69626816D1 (en) USE OF SELEGILIN FOR THE TREATMENT OF HEARING LOSS IN MAMMALS
BG104801A (en) Indole-2,3-dione-3-oxime derivatives for therapeutical use
TR199802137T2 (en) Use of phosphonic acid esters in relation to functional dysregulations of the brain and depression.
DE69915690D1 (en) ANTI-CONVULSIVE DERIVATIVES FOR TREATING POST-TRAUMATIC STRESS DISEASES
DE69831737D1 (en) neurotrypsin
BG103859A (en) The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions
DE3769497D1 (en) AGENT FOR CONTROLLING PHYTOPATHOGENIC MICROBES.
PT828483E (en) USE OF TROPOLONE DERIVATIVES AS ENZYME INOSITOL MONOPHOSPHATASE INHIBITORS
ES2122912A1 (en) Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents
ATE226445T1 (en) MACROPHAGE-STIMULATING PROTEIN FOR TREATMENT OF DISEASES OF THE NERVOUS SYSTEM
DE60012718D1 (en) FORECAST OF PTP LAR MEDIATED DISEASES
WO1999009963A3 (en) Use of cyclic phosphonic acid esters for the treatment of impaired cerebral function and depression